These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 22755150)
21. Switching from donepezil to galantamine: a double-blind study of two wash-out periods. Wilkinson DG; Howe I Int J Geriatr Psychiatry; 2005 May; 20(5):489-91. PubMed ID: 15852437 [No Abstract] [Full Text] [Related]
23. Delay in nursing home placement with donepezil. Schneider LS; Qizilbash N J Am Geriatr Soc; 2004 Jun; 52(6):1024-6; author reply 1026-7. PubMed ID: 15161477 [No Abstract] [Full Text] [Related]
24. [Concerning the contribution by Thomas Kaiser, Christiane Florack, Heinrich Franz, Peter Sawicki: donepezil in patients with Alzheimer's dementia. The AD2000 study. Med Klin 2005;100:157-60]. Vollmar HC; Butzlaff M Med Klin (Munich); 2005 Nov; 100(11):771; author reply 771. PubMed ID: 16328187 [No Abstract] [Full Text] [Related]
26. A case series of D-cycloserine added to donepezil in the treatment of Alzheimer's disease. Falk WE; Daly EJ; Tsai GE; Gunther J; Brown P J Neuropsychiatry Clin Neurosci; 2002; 14(4):466-7. PubMed ID: 12426422 [No Abstract] [Full Text] [Related]
27. Another advertisement for donepezil. Finucane TE J Am Geriatr Soc; 2004 May; 52(5):843; author reply 845-6. PubMed ID: 15086674 [No Abstract] [Full Text] [Related]
28. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Deleu D Neurology; 2002 Mar; 58(5):835-6; author reply 836. PubMed ID: 11889261 [No Abstract] [Full Text] [Related]
29. Donepezil for severe Alzheimer's disease. Hogan DB Lancet; 2006 Apr; 367(9516):1031-1032. PubMed ID: 16581383 [No Abstract] [Full Text] [Related]
30. Donepezil for severe Alzheimer's disease. Allsop D; Martin FL; Moore S; Fullwood NJ; Lancet; 2006 Jul; 368(9533):361; author reply 362. PubMed ID: 16876652 [No Abstract] [Full Text] [Related]
31. Abnormal movements with donepezil in Alzheimer disease. Amouyal-Barkate K; Bagheri-Charabiani H; Montastruc JL; Moulias S; Vellas B Ann Pharmacother; 2000 Nov; 34(11):1347. PubMed ID: 11098352 [No Abstract] [Full Text] [Related]
32. Another data/rhetoric mismatch on donepezil. Finucane TE J Am Geriatr Soc; 2005 Oct; 53(10):1831; author reply 1831-3. PubMed ID: 16181190 [No Abstract] [Full Text] [Related]
33. Measures to prevent Alzheimer's patients from discontinuing the use of cholinesterase inhibitors. Meguro K Psychogeriatrics; 2014 Sep; 14(3):210-1. PubMed ID: 25219960 [No Abstract] [Full Text] [Related]
34. Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study. Prasher VP; Adams C; Holder R; Int J Geriatr Psychiatry; 2003 Jun; 18(6):549-51. PubMed ID: 12789681 [No Abstract] [Full Text] [Related]
35. A combination therapy of donepezil and cilostazol for patients with moderate Alzheimer disease: pilot follow-up study. Arai H; Takahashi T Am J Geriatr Psychiatry; 2009 Apr; 17(4):353-4. PubMed ID: 19307864 [No Abstract] [Full Text] [Related]
36. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease. Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874 [No Abstract] [Full Text] [Related]
37. New drug available for Alzheimer's disease. Bailey C Colo Nurse; 1997 Mar; 97(1):12. PubMed ID: 9095790 [No Abstract] [Full Text] [Related]
38. Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment? Stiles MM; Martin S; Persons RK J Fam Pract; 2006 May; 55(5):435-6. PubMed ID: 16670040 [No Abstract] [Full Text] [Related]